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Abstract
1. The objective of this investigation was to test the influence of mammary cancer tissue
extract on the induction of various tumors by urethan. Three strains of female mice, Balb/c,
Zb and Db, were used in this experiment. 2. It was found that urethan was a multipotential
carcinogen in the induction of (a) lung tumor, ovarian hemorrhagic cyst, and hemorrhagic lesions
in various tissue in Balb/c mice, (b) lung tumor, hepatoma, leukemia, mammary cancer, Harderian
gland tumor and hemorrhagic lesions in various tissues such as spleen, mesenteric lymphnode,
liver and ovary in Zb strain, and (c) lung tumor, mediastinal lymphoma, leukemia, hepatoma and
hemorrhagic lesions in the liver and ovary in Db mice. 3. Mammary cancer tissue extract seemed
to have a promotive effect on the generalization of the mediastinal lymphoma induced by urethan
in Db female mice.
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The objective of this investigation was to test the influence of mammary
cancer tissue extract on the induction of various tumors with urethan. NETTLE-
SHIP, HENSHAW and MEYER1 reported that ethyl carbamate (urethan) induced
multiple pulmonary tumors in C3H mice exposed to roentgen rays. Since then,
it has been generally accepted that urethan was one of the carinogens that
produce lung adenomas in mice2-6. It was also demonstrated in our laboratory
that urethan augmented in mice the induction of leukemia by X-rays, estrogenic
hormone, or methy1cholanthrene7•
More recently, it was pointed out by TANNENBAUM and SILVERSTONE8 that
urethan was a multipotential carcinogen, capable of inducing or augmenting
pulmonary adenomas, mammary carcinoma, malignant mesenchymal tumors
in the interscapular fat, cystadenomas of the lacrimal gland, and blood cysts in
the liver in mice.
In addition, HESTON, VLAHAKIS and DERINGER9 reported that repeated
injections of urethan induce hepatomas which were larger in size than those in
the uninjected controls, although the numbers of the tumors were not shown to
be greater than those in the mice Teceiving a single injection. LIEBELT10 also
observed a high incidence of hepatoma in Zb mice, (higher in male than female)
after a single injection of urethan at birth.
Interesting findings of the studies here described include (1) development
of lung tumor, mediastinal lymphoma, systemic generalized stem cellleukemia,
hepatoma, hemorrhagic lesions in the liver, and enlarged hemorrhagic mesen-
teric lymphnode, and enlarged ovaries (polyfollicular ovaries) in an individual
female mouse of Zb strain, (2) the association of lung tumor, huge ovarian
hemorrhagic cyst in an individual Balb/c mouse and (3) the association of lung
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tumor, hepatoma, enlargement of ovaries and significant involvement of Peyer's
patches in an individual mouse of Db strain.
EXPERIMENTAL
Mice: Three strains of female mice, Balb/c (Albino mice without mam-
mary tumor agent), Zb (C3H without mammary tumor agent) and Db, have
been used in this experiment. They were fed on Purin Laboratory chow and
given water ad libitum. At this mouse colony, 62 Balb/c, 56 Zb, and 97 Db
female mice, all untreated, were autopsied during the observation of the ex-
perimental animals (1957-1959). According to the data shown in Table 1,
Balb/c female mice developed lung tumor (5%), leukemia (25%), mammary
cancer (11%) and hepatoma (3%) spontaneously at an average age of 670 days.
The Zb female mice developed mammary cancer (2%), leukemia (5%), andlung tumor (2%) spontaneously at an average age of 442 days. It was noted
that lung tumor (1%), leukemia (12%), and mammary cancer (7%) developed
spontaneously at an average age of 564 days in Db female mice.
Table 1. Incidence of the spontaneous tumors in Balb/c, Zb and Db female mice.




Strain of Lung Leukemia MaCa Hepatoma Averagemice ammal tumor I age (day)
Balb/c I 62 I 3 (5%) 15 (25%) 7 (11%) 2 (3%) 670iZb
I
56 I 1 (296) 3 (5%) 1 (2%) 0 442
Db 97 I 1 (1%) 12 (12%) 7 (7%) 0 564
Urethan injection: The experimental animals were injected intraperi-
toneally with urethan in 10 per cent aqueous solution, in the dosage of 1 mg/g
of body weight, every 4 days for 11 times, starting at weaning age. All animals
were observed for about 18 months after treatment and many were sacrificed
when they were near death during the course of the experiment. Sections of
varioues tissues were made for microscopic study.
Mammary cancer extract: As a source of mammary cancer tissue, spon-
taneous mammary cancer in C3H, Dba, Stoli, C58, Db F1 hybrid, and NH
strains and Db, Fn Mca-induced mammary cancer were used. The extracts of
the mammary cancer tissues were made as follows: Mammary tumors were
removed from the animals aseptically. A twenty per cent suspension of mam-
mary cancer cells in 0.9%saline solution was made, using a homogenizer. The
cell suspension was centrifuged twice at speed of 2,300 r. p. m. for twenty
minutes at O°e. The fat layer was then removed with a pipette and the super-
natant thus treated was filtered through a porcelain filter (~03). This filtrate
was stored at -70°C, and was used for inoculation.
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Treatment: We set up three groups of mice as follows:
(1) The first group received injections of urethan (every 4 days for 11
times) starting at weaning age, 5 weeks old.
(2) The second group received urethan injections followed by a single in-
jection of mammary cancer extract. (0.5 m!. intraperitoneally, with the last
injection of urethan: between 8 and 9 weeks of age).
(3) The third group received a single injection of mammary cancer extract:
(0.5 m!. intraperitoneally, between 8 and 9 weeks of age).
Females of each of three different strains of mice were divided into three
groups and were treated in the manner outlined above.
Experiment 1. Induction of tumors in :Balb/c female mice by urethan :
When Balb/c female mice were injected with mammary cancer extract at
9 weeks of age, lung tumor (7/27: 26%) and ovarian cyst (1/27: 4%) were
noticed. However, when urethan was administered to the animals, (a) lung
tumor (29/29: 100%) and (b) ovarian cyst (4/29: 14%) were observed in
association with hemorrhage in various organs including ovary, uterus, lung
and spleen, as shown in Table 2 and Fig. 1. When the urethan treatment was
followed by the injection of mammary cancer extract, the incidence of tumor
was almost the same as that in the group injected with urethan alone. Lung
tumor (26/32: 81%) and ovarian cyst (6/32: 19%) were observed, in asso-
ciation of hemorrhagic lesions in various organs. In addition, two leukemias
including mediastinal lymphoma, mammary cancer and hepatoma were noted
in the 32 experimental animals.






Leukemia I MaCa IHepatoma I~~e(d:;)of mice turnor (ML)
Urethan 29 29(100%) 0 (0) 0 0 469
Urethan and MaCa Extr. 32 26 (81%) 1(3%) (2)(6%) 1 (3%) 1 (3%) 441
MaCa Extr. 27 7 (26%) 0 (0) 0 0 533
From these data, urethan appeared to induce not only lung tumors but also
ovarian hemorrhagic cysts and numerous other hemorrhagic lesions including
hemorrhage in uterine wall. (Fig. 2.). However, mammary cancer extract did
not seem to produce any additional effects upon the urethan induced tumors in
Balb/c strain of mice.
Experiment 2. Induction of tumors in Zb female mice by urethan.
When Zb female mice were treated with mammary cancer extract alone at
9 weeks of age, one leukemia (4%), and two mediastinal tumors (7%)developed
in 27 experimental animals. However, neither lung tumors nor hepatomas were
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found in this group. On the other hand, when urethan was injected intraperi-
toneally, lung tumor (20/28: 71%), leukemia (6/28: 21%), including me·
diastinallymphoma (6/28: 21%), mammary tumor (1/28: 4%) and hepatoma
(5/28: ·18%) were observed. When mammary cancer extract was added to the
urethan treatment, the incidence of various tumors above described appeared to
be almost same as in the group injected with urethan alone. The percentage of
lung tumor was 72 per cent (18/25), leukemia 16 per cent (4/25), mediastinal
lymphoma 20 per cent (5/25), mammary cancer 8 per cent (2/25) and hepatoma
32 per cent (8/25). Throughout these three groups, hemorrhagic lesions in
various tissues such as liver, mesenteric lymphnodes, lungs were observed.
In this particular strain of mice (Zb mice) thus treated, it should be empha-
sized that various tumors such as lung tumor, hepatoma, Harderian gland tumor
and leukemia or mammary tumor were observed simultaneously in one and
the same animal as shown in Table 3 and Figs. 3,4.
Table 3. Induction of various tumors in Zb female mice by urethan.
Group I Num~eri Lung
I
Leukemia I C I I Averageof mIce tumor (ML) Ma a Hepatoma age (day)
Urethan 28 i 20 (71%) 6(21%) (6)(21%) [I (4%) 5 (18%) 430
Urethan and MaCa Extr. 25 118 ~2%) 4(16%) (5)(20%) I 2 (8%) 8 (32%) 470IMaCa Extr. 27 1(496) (2)(796: i 0 0 474
The pattern of the aSSOCIatIOn of various turnors in an individual animal
seems to be fairly uniform in this experiment. Therefore, it appeared likely
that urethan was a multipotential carcinogen in this strain of mice.
Experiment 3. Induction of tumors in Db female mice by urethan.
As shown in Table 4, urethan induced not only lung tumor but also me·
diastinal lymphoma, hepatoma and hernorrhage in the liver in Db mice. If
mammary cancer extract was injected into the mice after urethan treatment,
mediastinal lymphoma appeared to generalize, subsequently resulting in leuke-
Fig. 1. Balb/c #49 female: Urethan treatment
(1) Lung tumor. (2) Ovarian hemorrhagic cyst.
Fig. 2. Balb/c #5931 female: Urethan treatment
Hemorrhage in the uterine wall and ovaries.
Fig. 3. Zb #1107 female: Urethan treatment
(1) Leukemia (stem-cell). (2) Mediastinal lymphoma. (3) Hepatoma.
(4) Hemorrhagic mesenteric lymphnode. (5) Enlarged Peyer's patches.
(6) Hemorrhagic lesions in liver, spleen. (7) Lung tumor.
Fig. 4. Zb #1128 female: Urethan treatment
(1) Lung tumor. (2) Mammary tumor. (3) Enlarged cervicallymphnodes and spleen.
(4) Numerous enlarged Peyer's patches. (5) Ovarian hemorrhagic cyst.
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mia. Mammary cancer extract injected seemed to have a stimulative effect upon
the female endocrine organs.
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The results may be described as follows: (1) Lung tumor: When
mammary cancer extract was injected in Db female mice, no lung tumor deve-
loped. However, if either urethan alone or urethan combined with mammary
cancer extract were administered intraperitoneally, lung tumor developed in
44per cent (11/25) in the former group and in 32 per cent (11/34) in the latter
group. (2) Leukemia and mediastinal lymphoma: When mammary cancer
extract was injected into the animal, only one out of the 26 mice developed
leukemia. Mediastinal tumor was found in none of them. However, when
urethan was administered intraperitoneally to the same strain of mice, mediastinal
lymphoma was noted in as high as 28 per cent (7/25), but no leukemia was
detected. If mammary cancer extract was injected after the urethan treatment,
the incidence of mediastinal lymphoma was 38 per cent (13/34), and the inci-
dence of leukemia was 11 out of 34 animals, or an incidence of 32 per cent.
These results suggested that the mammary cancer extract had a synergistic action
with urethan in the induction of leukemia in Db mice. (3) Mammary cancer:
When urethan was administered to the Db female mice, mammary cancer deve-
loped in two out of 25 mice (8%), but when mammary cancer extract alone or
mammary cancer extract and urethan were given to the mice, mammary cancer
developed in 31 per cent (8/26) and in 26 per cent (9/34), respectively. From
these data, it seemed likely that mammary cancer extract had a promotive effect
on the development of mammary cancer, regardless of the administration of
Fig. 5. Papillary adenocarcinoma of the lung in Zb #1107 female treated with urethan. Note
marked hemorrhage in alveolar lumen. Hematoxylin and eosin. X 80
Fig. 6. Infiltration of leukemic cells in the lymphnode of Zb # 1107 female treated with
urethan. Hematoxylin and eosin. X 110.
Fig. 7. Infiltration of leukemic cells in the areas surrounding the blood vessels and difuse
hemorrhage in both tubules and capillaries in the kidney of Zb #1107 female tre[lted
with urethan. Hematoxylin and eosin. X 80.
Fig. 8. Cystadenomatous lesion in mammary tumor of Zb #1128 female treated with urethan.
Hematoxylin and eosin. X 90.
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urethan to the mice. (4) Hepatoma: The injection of mammary cancer extract
did not seem to influence the occurrence of spontaneous hepatoma (0/28: 0 %).
If mammary cancer extract were injected with urethan treatment, the incidence
of hapatoma was 6 per cent (2/34), in contrast to the group injected with urethan
alone, in which the hepatoma developed in 5 out of the 25 animals (20%). These
data suggest the possibility that urethan may accelerate the induction of he-
patomas and mammary cancer extract may have a suppressive effect on the
induction of hepatoma. Further investigation will be needed for the confirmation
of these interesting results. (5) Hemorrhagic lesions: When either urethan or
urethan combined with mammary cancer extract was injected into the mice,
hemorrhagic lesions, mainly in the liver tissue occurred in 11 out of 25 and 10
out of 34 animals, respectively, whereas no hemorrhagic lesions were found in
the group injected with mammary cancer extract alone.
DISCUSSION
Our experiment indicated that urethan was a multipotential carcinogen' to
the female in Balb/c, Zb and Db strain of mice.
TANNENBAUM and SILVERSTONE8 had demonstrated previously that urethan
was a multipotential carcinogen, capable of inducing pulmonary adenomas,
mammary carcinomas, malignant mesenchymal tumors in interscapulary fat,
cystadenomas of the lacrimal gland and blood cysts in the liver in C57 Black x
C3H F1, Dba, and C3H mice. In their work, it was speculated that urethan
would be carcinogenic for other tissues and for other species. The following
changes were observed in our experiment: hemorrhagic lesions in the uterine
wall, ovarian hemorrhagic cyst and lung tumor in Balb/c; lung tumor, hepa-
toma, leukemia, ovarian hemorrhagic cyst, mammary cancer, Harderian gland
tumor, and hemorrhagic lesions of various tissue such as spleen, mesenteric
lymphnode, liver, ovary in Zb mice; and lung tumor, mediastinal lymphoma,
leukemia, hepatoma, and hemorrhagic lesions in the liver and ovary in Db mice.
Since the report of NETTLESHIP, HENSHAW and MEYER (1943)\ (1944)1\
urethan had been considered as a lung specific carcinogen. JAFFE (1944)12,
(1947)13, LARSEN and HESTON (1945)14 and LARSEN15 later confirmed their
results. However, NOBLE and MILLAR (1948)16 noticed lymphosarcoma in Swiss
albino mice, which showed extensive spread to gut, liver and kidneys, three
or four months after a single subcutaneous administration of 25 per cent urethan
in a 5 per cent solution of zinc acetate (0.1 ml/gm). He also found a malignant
hemangioendothelioma in his experiment. SINCLAIR (1949)17 found adenomatous
lesions in C3H mice besides lung tumors. Since then, it has been speculated
that urethan might be a carcinogen in tissues other than lung. SALAMAN and
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ROE (1953)18, GRAFFI, VLANYNCK, HOFFMAN and SCHULZ (1953)19 demonstrated
that skin tumor was induced by urethan and croton oil, concluding that urethan
was an initiator for mouse skin tumor. When BERENBLUM and HARAN (1955)20
tried to confirm these results regarding the initiating action of urethan, they
noticed lesions of the liver, resembling hemangiomas, but proving histologically
to be hemorrhages with necrosis of liver parenchyma.
In 1957, KIRSCHBAUM and his associates21 found that urethan had a poten-
tiating effect on the induction of mouse leukemia by X-rays. Later, we (1958Y
reported that urethan augmented the induction of leukemia in mice by X-rays,
estrogenic hormone, and methylcholanthrene, respectively. When the influence
of urethan on the high incidence of spontaneous leukemia of presumably viral
etiology in such strains as AKR and C58 was studied in our laboratory (1961)22,
it was demonstrated that the onset of leukemia was slightly accelerated by this
drug.
In the present experiment, we also observed various locations of hemor-
rhagic lesion: in the tissue of ovary, uterus, lung, spleen, and thymus in Balb/c
female mice; and liver, lung, mesenteric lymphnode, kidney, abdominal cavity,
liver, lung and intestine in Db and Zb female mice. These hemorrhagic lesions
have been described by HESTON, VLAHAKlS and DERINGER (liver)9, TANNENBAUM
and SILVERSTONE (liver)8, KIRSCHBAUM and BELL and GORDON Oiver)23, ROE
and SALAMAN (hepatic tumors)2', NOBLE and MILLAR (a slower growing tumor
behind the humerus)16, KAWAMOTO, KIRSCHBAUM, IBANEz, TRENTIN and TAYLOR
(liver, intestines, pancreas)22 and DOLJANSKI and ROSIN (liver)2ti. TANNENBAUM
and SILVERSTONE8 have pointed out that the blood cysts in the livers of urethan-
treated mice were the results of vascular injury and that they were not neoplasia.
BERENBLUM and HARAN20 seemed to agree with TANNENBAUM8.
It was of interest that a significantly higher incidence of hepatomas was
found in the Zb and Db female mice treated by urethan, but not in Balb/c
female mice. HESTON, VLAHAKIS and DERINGER9 reported a high incidence of
hepatomas in C3H males that received 8 injections of 20 mg urethan each.
However, the occurrence was not shown to be greater than that in the males
receiving one injection. According to LIEBELT and his associates lO, a single
injection of urethan at birth induced a high incidence of hepatomas and leuke-
mias in Zb mice. From these data, urethan was obviously carcinogenic in the
liver tissue in mice. However, it did not seem to act as carcinogen in the liver
of Balb/c female mice. The induction of hepatomas by urethan may depend
upon the susceptibility of strain of mice.
When Db female mice were injected with urethan, seven mediastinallym-
phomas but no leukemias were found in 25 female mice. However, if mammary
cancer extract was added to the urethan treatment, then not only mediastinal
9
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lymphomas (13 out of 34 mice), but also leukemias (11 out of 34 mice) de-
veloped. On the other hand, when mammary cancer extract alone was admi-
nistered to the mice, no mediastinal lymphoma and only one leukemia developed
among 28 experimental animals. These data suggested that urethan induced
mediastinal lymphomas in Db mice and that the mammary cancer extract aided
in the generalization of the mediastinal lymphoma. Considering our previous
results7 that suggested a synergistic effect of urethan and estrogenic hormone on
the induction of leukemia in castrated C57 Black mice, the data in the present
experiment seemed to indicate need for further investigation of the relationship
between sex hormone and urethan.
When either urethan alone or urethan combined with mammary cancer
extract was injected to Zb female mice, leukemias developed in 21 per cent and
16 per cent, respectively, whereas only one leukemia developed in 27 animals
(4%) in the group injected with mammary cancer extract alone. Urethan ap-
peared to be a leukemogen in the Zb strain of mice in this experiment.
Studies have been made on the induction of tumors by various tumor
viruses and enhancement by chemical agents: According to Rous et al. 26 ,27, it
was demonstrated that significantly numerous warts were induced in rabbits
when treated with Shope papilloma virus followed by painting with tar, although
the incidence was low or negligible in the animals either treated with tar alone
or injected with the virus alone. AHLSTROM and ANDREwEs23 also demonstrated
enhancement of the Shope fibroma virus-induced tumor by applying either addi-
tional tar or carcinogenic hydrocarbons.
Along the same line, it was reported by DURAN-REYN ALS29 that methyl-
cholanthrene induced either benign or malignant local tumors in cortisone-treated
mice, when vaccinia-virus was injected intradermally later. However, only
local lesions were noted when animals thus treated were injected with the vac-
cinia-virus alone.
More recently, RowsON et a130• inoculated newborn mice with polyoma
virus, followed by the dermal application of 9: lO-dimethyl-l,2-benzanthracene
(DMBA) or 3, 4-benzpyrene (BP) with the subsequent administration of tumor
promoting factor (croton oil). He demonstrated that mice inoculated with po-
lyoma virus when newly born and later treated by application to the skin of
carcinogenic or tumor-promoting agents developed significantly more polyoma-
type tumors than mice which received the virus alone.
When our experiment was initiated, serological test for polyoma virus to
the experimental animals was not conducted. Therefore, it was unfortunate
that the possibility of contamination with polyoma virus could not be ruled out
in our experiment. However, neither parotid tumors nor kidney tumors which
were most common in polyoma type tumors were observed in our experiment.
10





1. The objective of this investigation was to test the influence of mammary
cancer tissue extract on the induction of various tumors by urethan. Three
strains of female mice, Balb/c, Zb and Db, were used in this experiment.
2. It was found that urethan was a multipotential carcinogen in the induc-
tion of (a) lung tumor, ovarian hemorrhagic cyst, and hemorrhagic lesions in
various tissue in Balb/c mice, (b) lung tumor, hepatoma, leukemia, mammary
cancer, Harderian gland tumor and hemorrhagic lesions in various tissues such
as spleen, mesenteric lymphnode, liver and ovary in Zb strain, and (c) lung
tumor, mediastinal lymphoma, leukemia, hepatoma and hemorrhagic lesions
in the liver and ovary in Db mice.
3. Mammary cancer tissue extract seemed to have a promotive effect on
the generalization of the mediastinal lymphoma induced by urethan in Db female
mIce.
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